Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Borel Fields's Profile
Displaying 201-250 of 343 result(s).
CYDY CytoDyn Inc
01/06/2021 11:29:50 PM
At the 50% interim, a 50% reduction (3)
CYDY CytoDyn Inc
01/06/2021 11:12:25 PM
Sure, I'll toss in my wild-ass gues (9)
CYDY CytoDyn Inc
01/06/2021 2:06:13 AM
Thanks so much. Another ten or twel (2)
CYDY CytoDyn Inc
01/05/2021 8:15:55 PM
Thanks, CTMedic, I missed that unti (6)
CYDY CytoDyn Inc
01/05/2021 6:03:09 PM
"Thinning, Leaky Brain Blood Vessel (1)
CYDY CytoDyn Inc
01/04/2021 3:50:06 PM
Does that sound like sequencing? GM (1)
CYDY CytoDyn Inc
01/04/2021 3:34:54 PM
You are correct that I was taking t
CYDY CytoDyn Inc
01/04/2021 2:20:06 PM
Help, please, re: leron/lenzi compa (1)
CYDY CytoDyn Inc
01/04/2021 10:50:30 AM
Leronlimab's supply from Samsung is (2)
CYDY CytoDyn Inc
01/04/2021 10:08:33 AM
Not a doc, but both now exclude the (2)
CYDY CytoDyn Inc
01/03/2021 6:26:45 PM
Rub - Given the number of platforms (2)
CYDY CytoDyn Inc
01/02/2021 9:27:14 PM
Anyone know details of NEWS2? I'm w (2)
CYDY CytoDyn Inc
01/02/2021 8:19:45 PM
Good arguments against using all-ca (3)
CYDY CytoDyn Inc
01/02/2021 1:28:54 AM
Another case saying EUAs take time: (3)
CYDY CytoDyn Inc
01/01/2021 2:44:57 AM
The good side of all cause mortalit (5)
CYDY CytoDyn Inc
12/29/2020 7:21:16 PM
Is the 1/21 effective date a typo o
CYDY CytoDyn Inc
12/26/2020 12:47:17 PM
CD-12 survivors are an ongoing long
CYDY CytoDyn Inc
12/26/2020 1:48:20 AM
Certainly, the FDA can see the deat
CYDY CytoDyn Inc
12/22/2020 1:58:49 AM
I worked for a while in a quantitat (3)
CYDY CytoDyn Inc
12/20/2020 2:11:56 AM
Clickbait is enough to track humans (2)
CYDY CytoDyn Inc
12/16/2020 2:23:57 PM
Samsung Mab capacity expanding - gr (6)
CYDY CytoDyn Inc
12/15/2020 11:30:36 AM
Use all the data: P(survive to 42) (6)
CYDY CytoDyn Inc
12/13/2020 7:08:24 PM
What happens at trial sites the day (1)
CYDY CytoDyn Inc
12/12/2020 10:34:46 PM
Was the "expanded access" tab on th (1)
CYDY CytoDyn Inc
12/12/2020 3:31:27 PM
Perfect. Thanks so much - I get the (1)
CYDY CytoDyn Inc
12/12/2020 11:09:49 AM
Thanks, Tech Guru, I used to think
CYDY CytoDyn Inc
12/10/2020 11:56:32 PM
If that's what they did, it is wron
CYDY CytoDyn Inc
11/25/2020 12:16:50 AM
No. I'm talking about post 66504
CYDY CytoDyn Inc
11/24/2020 11:03:32 PM
Exactly. The big thing is being cle
CYDY CytoDyn Inc
11/24/2020 5:33:38 PM
Simple product P(survive 42) = (# s (1)
CYDY CytoDyn Inc
11/24/2020 4:58:26 PM
The Cox model is the generalization (2)
CYDY CytoDyn Inc
11/16/2020 5:37:53 PM
Even 14-days post-293 enrollees, a (2)
CYDY CytoDyn Inc
11/13/2020 3:18:44 PM
Another view: Maraviroc, a small mo (5)
CYDY CytoDyn Inc
11/06/2020 9:46:16 PM
Repeating: information lies in even (5)
CYDY CytoDyn Inc
11/06/2020 9:42:21 PM
I hope I can help on the power fron (10)
CYDY CytoDyn Inc
10/29/2020 12:16:49 AM
Ohm - I've been trying to understan (4)
CYDY CytoDyn Inc
10/28/2020 6:14:15 PM
Only 6.5% of the placebo patients i (3)
CYDY CytoDyn Inc
10/28/2020 4:20:34 PM
Agree - it's clearly an "uneven pla (12)
CYDY CytoDyn Inc
10/26/2020 8:13:50 PM
Exactly. Information is measured in
CYDY CytoDyn Inc
10/21/2020 12:23:45 AM
So - the Meso GvHD CRL wasn't on hi (2)
CYDY CytoDyn Inc
10/21/2020 12:10:22 AM
Increasing mortality to 42 days is (4)
CYDY CytoDyn Inc
10/20/2020 10:06:17 PM
Rahman was just 13 months into runn
CYDY CytoDyn Inc
10/20/2020 12:39:58 PM
Let's not forget that OncoImmune pu
CYDY CytoDyn Inc
10/20/2020 10:22:09 AM
It's been a couple of hours - where (4)
CYDY CytoDyn Inc
10/18/2020 5:02:34 PM
Agree, sub-group analysis sucks - l
CYDY CytoDyn Inc
10/18/2020 11:50:42 AM
We will do a cohort (S alone, C alo (1)
CYDY CytoDyn Inc
10/16/2020 7:33:25 PM
Enrollment during interim analysis?
CYDY CytoDyn Inc
10/16/2020 7:24:08 PM
The 7-category ordinal scale: 1=dea (3)
CYDY CytoDyn Inc
10/16/2020 7:12:14 PM
Endpoint changes based solely on in (1)
CYDY CytoDyn Inc
10/16/2020 1:14:09 AM
By what process did OncoImmune deci
Go to page:
  • << First
  • < Previous
  • 4
  • 5
  • Next >

Recent Articles

  • Navigating High-Stress Careers: Insights from Executives
  • Banco Comercial Português Updates on Share Buy-Back Programme Activity
  • Centene Corporation Faces Class Action Over Investor Losses
  • Banco Comercial Português (BCP) Shares Buy-Back Program Update
  • Insights into Gilead Sciences, Inc. and Recent Developments
  • Legal Action Initiated Against Flywire Corporation's Officers
  • Replimune Group Faces Legal Action Amid Stock Price Decline
  • Investors Seek Clarity on Simulations Plus Financial Concerns
  • Shocking Survey: How Much Would You Sacrifice For Wealth?
  • Harnessing Natural Testosterone Boosters for Optimal Muscle Growth
  • Neuralink’s Recent Developments and Future Aspirations Explained
  • Global AI Cooperation: China's Vision for the Future of Technology
  • Investment Insights from Experts: Maximize Your $10,000 Now
  • Shiba Inu's 3,000% Growth Potential in Competitive Memecoin Market
  • Investors Seek Justice in Biohaven Ltd. Class Action Lawsuit
  • Class Action Lawsuit Against Hims & Hers Health, Inc. Explained
  • Sarepta Therapeutics Faces Legal Challenges Amidst Controversies
  • Investors Take Note: Class Actions Against Western Asset Management
  • Mereo BioPharma Faces Scrutiny as Investigation Unfolds
  • Centene Corporation Faces Class Action Lawsuit Amidst Losses
  • Investigation Unfolds for Capricor Therapeutics Amid Stock Fluctuations
  • KouShiCare Revolutionizes Dry Eye Treatment with LuminEyes
  • Philanthropic Impact of the Erb Family Foundation on Alzheimer's
  • Celebrating Innovation in Alzheimer’s Research: Awards Announcement
  • Investing in People: A Path to Prosperity and Growth in China
  • New Yorkers Discover the Essence of Shanghai's Culture
  • Bill Gates' Porsche 959 Saga: A 13-Year Journey to Freedom
  • Building Stronger Economic Connections Between China and the US
  • Discovering the Top Large Cap Stocks: Growth and Potential
  • Recent Class Action Lawsuit Filed Against iRobot Corporation
  • 3D Systems Faces Class Action Lawsuit Amid Financial Concerns
  • Petco Faces Class Action Lawsuit Amid Financial Turmoil
  • Class Action Alert: Investors urged to act on Reckitt Benckiser
  • Understanding Lineage, Inc.'s Investor Investigations and Impacts
  • Altimmune, Inc. Under Investigation for Possible Fraud Claims
  • Groupon, Inc. Faces Investor Scrutiny Amid Accounting Allegations
  • Investigation Unfolds for Tesla Investors Amid Concerns
  • Legal Investigations Affecting Multiple Tech Companies Unveiled
  • Unicycive Therapeutics Under Investigation by Pomerantz Law Firm
  • Investigation Opened for American Outdoor Brands Investors
  • Pomerantz Investigates Potential Securities Fraud at Abacus
  • Stock Update: Reckitt Benckiser Group Faces Class Action Suit
  • Investigating Legal Claims Related to National Grid plc
  • Investors Notice Securities Investigations of Harrow, Inc.
  • Geely Automobile Holdings: Legal Inquiry into Investor Claims
  • Neogen Corporation Faces Investigation Amidst Stock Decline
  • Class Action Lawsuit for Investors in Broadmark Realty Capital
  • Class Action Filed Against Fortrea Holdings: Key Insights
  • Investigating Zeo Energy Corp: A Call to Investors for Justice
  • PetMed Express Investors Targeted by Law Firm Investigations
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site